Patents & Technology
Core Technology Patent
Registered domestically and internationally as "Antiviral Agent Against Viruses Infecting Animal Cells"
🇰🇷
Korea
Patent Registered
Antiviral agent against viruses infecting animal cells
🇨🇳
China
Patent Registered
Antiviral agent against viruses infecting animal cells
🇪🇺
Europe
Patent Registered
Antiviral agent against viruses infecting animal cells
🇺🇸
United States
Patent Registered
Antiviral agent against viruses infecting animal cells
Antiviral efficacy of innovative antibody verified through domestic and international publications
2021
Simultaneous treatment effect of COVID-19 and influenza using 3D8 scFv (Biorxiv)
2021
Preventive and therapeutic effects of NVG308 against Tamiflu-resistant influenza A virus
2006
Broad-spectrum antiviral efficacy of NVG308 — validated against 7 animal viruses
2003
Isolation of scFv with nucleic acid hydrolyzing capability and elucidation of 3D structure